PODCAST

Urology

ReachMD

science & medicine medicine

All Episodes

00:00:00

Prostate Cancer: Laparoscopic v. Open Procedures

Urology ·

2008/08/08

Host: Mark Nolan Hill, MD Guest: Jim Hu, MD, MPH Research indicates that demand for minimally invasive prostatectomy is growing, from 12 percent to more than 30 percent of our candidate patients over a recent two-year span. But research also tells us that there are still drawbacks to a laparoscopic approach to prostate cancer. What are the immediate and enduring pitfalls to laparoscopy, and are these concerns outweighed by the perceived benefits? Dr. Jim Hu, assistant professor of

00:00:00

Finasteride Dilema: To Treat or Not To Treat?

Urology ·

2008/07/02

Guest: Stewart Justman, PhD Host: Maurice Pickard, MD Professor Stewart Justman discusses his new book "Do No Harm" in which the results of finasteride trial that ended in 2003 are looked at again. By reducing the size of the gland, what previously had appeared to be causing increased aggressive cancers may now be called into question. We will have to decide whether a healthy man should take a treatment to prevent a disease he may never get and if he did might be better off in not

00:00:00

A Magic Bullet for Prostate Cancer or a Medical...

Urology ·

2008/07/02

Host: Maurice Pickard, MD Guest: Stewart Justman, PhD Professor Stewart Justman discusses his new book "Do No Harm" in which the results of the Prostate Cancer Prevention Trial cause us to reflect on Hippocratic ethical principals of 300BCE in our present practice. Finasteride leaves us with an ambiguity of reducing the incidence of cancer but also associated with a higher rate of aggressive neoplasm. In chemoprevention is any risk too much to be expectable? Hosted by Maurie

00:00:00

Robotic Surgical Advances for Prostatectomies

Urology ·

2008/06/11

Guest: Ash Tewari, MD Host: Bruce Bloom, DDS, JD Does robotic surgery for radical prostatectomy provide better outcomes? Our guest Dr. Tewari Ash, director of robotic prostatectomy and prostate cancer-urologic oncology outcomes at Brady Urology Institute and associate professor of associate professor of public health and outcomes in the Department of Public Health and Outcomes at The Weill Medical College of Cornell University talks with host Dr. Bruce Bloom about the history,

00:00:00

The Advance of the Robot for Prostatectomy

Urology ·

2008/06/11

Guest: Ash Tewari, MD Host: Bruce Bloom, DDS, JD Would experienced video gamers have a leg up in operating the DaVinci robot used in robotic surgery for prostate cancer? Dr. Ash Tewari, associate professor of urology, and director of Robotic Prostatectomy & Prostate Cancer-Urologic Oncology Outcomes at Brady Urology Institute, and associate professor of public health and outcomes at the Weill Medical College of Cornell University, answers this question posed by your host, Dr. Bruce

00:00:00

Robotic Surgery for Prostate Cancer Patients

Urology ·

2008/06/11

Host: Bruce Bloom, DDS, JD Guest: Ash Tewari, MD Are your patients potential candidates for robotic prostatectomy? How precisely does robotic surgery treat prostate cancer while maintaining urinary and sexual function? Host Dr. Bruce Bloom addresses these questions with Dr. Ash Tewari, associate professor of urology, and director of Robotic Prostatectomy & Prostate Cancer-Urologic Oncology Outcomes at Brady Urology Institute at Weill Cornell Medical College. Dr. Tewari

00:00:00

Lance Armstrong: Leading Cancer Advocacy

Urology ·

2008/05/19

Guest: Craig Nichols, MD Host: Mark Nolan Hill, MD Testicular cancer has received significant media attention in recent years, thanks in part to the very public cancer battle of cyclist Lance Armstrong during the late 1990s. The treatment aspect of Armstrong’s spirited and ultimately successful drive to beat cancer was led by Dr. Craig Nichols who, at the time, was a professor of medicine in the division of hematology/oncology at the Indiana University School of Medicine

00:00:00

Testicular Cancer: Advising Our Patients on Fertility...

Urology ·

2008/05/19

Host: Mark Nolan Hill, MD Guest: Craig Nichols, MD When patients think of testicular cancer, they immediately think of two ramifications: the impact on their fertility and on their sexuality. Are these concerns well-founded? How should we counsel our patients on these issues? Dr. Craig Nichols, medical director of lymphoma and testicular cancer research at Providence Portland Medical Center in Portland, Oregon, and an internationally respected expert on testicular cancer, explores

00:00:00

Testicular Cancer: Raising Already Lofty Cure Rates

Urology ·

2008/05/19

Host: Mark Nolan Hill, MD Guest: Craig Nichols, MD Diagnosed in thousands of American men each year, testicular cancer has proven highly sensitive to current treatment regimens. Host Dr. Mark Nolan Hill evaluates the most common therapies for testicular cancer with Dr. Craig Nichols, medical director of lymphoma and testicular cancer research at Providence Portland Medical Center in Portland, Ore., and an internationally respected expert on testicular cancer. Are there significant

00:00:00

Screening Modalities for Testicular Cancer

Urology ·

2008/05/19

Host: Mark Nolan Hill, MD Guest: Craig Nichols, MD If detected in its early stages, we have great success in curing testicular cancer. What are our most effective screening measures? How should we instruct our patients to be vigilant with their own self-exams, or is this the best approach? Dr. Craig Nichols, medical director of lymphoma and testicular cancer research at Providence Portland Medical Center in Portland, Ore., and an internationally respected expert on testicular

00:00:00

Targeting Individualized Cancer Treatment

Urology ·

2008/05/15

Guest: Walter Stadler, MD Host: Bruce Bloom, DDS, JD Targeted and Individualized Therapies for Cancer. Where are we? What's on the horizon? Associate Dean of Clinical Research, Professor of Medicine and Director of the Genitourinary program at the University of Chicago Pritzker School of Medicine, Dr. Walter Stadler, cites the majority of patients struggling with the side effects - while grasping for the benefits - of cancer therapy as a necessity for individualized therapy. Dr

00:00:00

Using Testosterone for Refractory Prostate Cancer

Urology ·

2008/05/15

Host: Bruce Bloom, DDS, JD Guest: Walter Stadler, MD Host Dr. Bruce Bloom welcomes Dr. Walter Stadler, professor of medicine and director of the genitourinary program at the University of Chicago Pritzker School of Medicine. We are still working toward a highly effective treatment for hormone refractory prostate cancer. Could a paradoxical treatment with high-dose testosterone hold the key to a cure? Dr. Stadler details current clinical research on this somewhat controversial

00:00:00

Prostate Cancer Predictability: Can We Anticipate a...

Urology ·

2008/05/07

Host: Bill Rutenberg, MD Guest: Andrew Vickers, PhD Can you predict a man’s risk of prostate cancer 25 years in the future? The data from this study indicates that PSA levels before age 50 is an indicator of future prostate cancer. Find out more about the prospective study conducted by a team of researchers from Memorial Sloane Kettering. Epidemiologist Andrew Vickers talks with host Dr. Bill Rutenberg about what the GP can take from this study What does a slightly elevated, but

00:00:00

The Surgeon's Learning Curve

Urology ·

2008/05/07

Host: Bill Rutenberg, MD Guest: Andrew Vickers, PhD We all know that practice makes perfect, but how much practice is necessary to be considered beyond the learning curve? In this segment, Dr. Andrew Vickers shares his research in which his team evaluated the surgical outcomes for radical prostectomies based on chemical recurrence. What do the outcomes of this study indicate about the training and experience level of surgeons? Join us to find out.

00:00:00

Neurogenic Erectile Dysfunction

Urology ·

2008/03/04

Guest: Anthony Bella, MD Host: Leslie P. Lundt, MD Vascular causes of ED may be the most common type of ED, but neurogenic ED is often the most difficult to treat. What should the clinician know about diagnosing and treating erectile dysfunction of neurogenic origin? Urologist Dr. Anthony Bella discusses his research with host Dr. Leslie Lundt.

00:00:00

Treating Peyronie's Disease

Urology ·

2008/03/04

Guest: Anthony Bella, MD Host: Leslie P. Lundt, MD Peyronie’s Disease is more common than most physicians realize, affecting 1 in 20 men. Does it always require surgery? Urologist Dr. Anthony Bella discuss treatment options with host Dr. Leslie Lundt.

00:00:00

Peyronie's Disease: Evaluation and Diagnosis

Urology ·

2008/03/04

Guest: Anthony Bella, MD Host: Leslie P. Lundt, MD The management of Peyronie's disease (PyD) presents several challenges to the clinician. Despite progress in the understanding of PyD on several fronts, it remains a physically and psychologically devastating condition for the affected patient and his partner. Anthony Bella MD, an international expert on PyD, joins host Dr. Leslie Lundt to discuss screening for this condition which affects 5% of adult males.

00:00:00

Management of Small Renal Tumors

Urology ·

2008/02/29

Guest: Robert Thompson, MD Host: Gary Kohn, MD Small Renal tumors: Are patients being properly counseled? With your host, Dr. Gary Kohn, is Robert "Houston" Thompson, Urologic Oncology Fellow, at Memorial Sloan Kettering Cancer Center in New York. Join the discussion as Dr. Thompson covers the management of small renal tumors, highlighting survival rates of patients treated with partial vs. radical nephrectomies.

00:00:00

Small Renal Tumors: Clinical Judgement of Partial vs....

Urology ·

2008/02/29

Host: Gary Kohn, MD Guest: Robert Thompson, MD Small renal tumors and surgical judgement. Amongst patients with small renal tumors, what is the benefit of a partial nephrectomy vs. a total, or radical nephrectomy? Dr. Robert Thompson, a urologic oncology fellow at Memorial Sloan Kettering Cancer Center, discusses research published in the Journal of Urology with your host, Dr. Gary Kohn.

00:00:00

Current Treatments for Peyronie's Disease

Urology ·

2008/02/27

Guest: Paul Shin, MD Host: Larry Kaskel, MD What is known about the cause of Peyronie's Disease, and what are the latest treatments? Join host Dr. Larry Kaskel to discuss Peyronie's Disease with our guest, Dr. Paul Shin.

80 results

Urology

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事